key: cord-0851322-ky1bdpzx
authors: Sammour, Yasser; Spertus, John A.; Shatla, Islam; Main, Michael L.; Sperry, Brett W.
title: Reply: Telehealth: The Future of Consultations?
date: 2022-03-28
journal: JACC Heart Fail
DOI: 10.1016/j.jchf.2022.01.013
sha: fbc3151e8eeffba81d87b38ccbb7b542c1cb2f3d
doc_id: 851322
cord_uid: ky1bdpzx

nan

Telehealth: The Future of Consultations?

We read with interest the paper by Sammour et al, 1 in which a similarity was found in the outcomes of patients with heart failure seen in person compared with those seen via telehealth. Their results support telemedicine, as it enables sufficient continuity of care for patients amid a climate antagonistic to inperson consultation.

The efficacy of telehealth is further demonstrated by Yun et al. 2 however, we did not find differences in mortality between the 2 telehealth modes.

We believe that telehealth is here to stay, particularly with the continued pressure for remote medical care given the emergence of novel COVID-19 variants.

Our data suggest that in-person visits can be supplemented safely with telehealth visits in a hybrid model.

We concur that further studies are needed to identify best practices for future implementation of telehealth to improve outcomes and experience for patients.

In their network meta-analysis (NMA), and, most importantly, the certainty of the evidence. 2 For example, Busse et al 3 reported both the SUCRA and certainty of evidence in their NMA of non-low-back pain; fentanyl ranked as the highest effect for pain relief (<2 h after treatment) but proved to have lowor very-low-certainty evidence. This means that it is very unsure that the high effect of fentanyl is true. 4 

Outpatient management of heart failure during the COVID-19 pandemic after adoption of a telehealth model

Patient satisfaction with telehealth for outpatient cardiovascular care during the COVID-19 pandemic

Comparison of video and telephone visits in outpatients with heart failure

Practice patterns and patient outcomes after widespread adoption of remote heart failure care

The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors' institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.